Indication and dosing Flashcards
(48 cards)
Humira dose on RA/PsA/AS
400mg every 2 weeks
Humira dosing on Uveitis/PP/HS
80mg then 40mg every 2 weeks, beginning 1 week after initial dose
Humira dosing on HS
160mg on day 1 then 80mg on day 15 then 40mg weekly or 80mg every 2 weeks on day 29
Humira dosing on CD/UC
160mg day 1 then 80mg on day 15 then 40mg every 2 weeks beginning on day 29
Enbrel dosing on RA/PsA/AS
50mg weekly
Enbrel dosing on PP
50mg twice weekly for 3 months then 50mg weekly
Cimzia dosing on RA/AS/nr-axSpA/PsA
400mg weeks 0, 2, 4 then 400mg ever 4 weeks or 200mg every 2 weeks
Cimzia dosing on PP
400mg every 2 weeks (<90kg - 400mg week 0, 2, 4 then 200mg every 2 weeks)
Cimzia dosing on CD
400mg week 0, 2, 4 then 400mg every 4 weeks
Simponi dosing on RA/PsA/AS
50mg monthly (IV - 2mg/kg at week 0, 4, then every 8 weeks); for RA - with MTX
Simponi dosing on UC
200mg week 0 then 100mg week 2 then 100mg every 4 weeks
Remicade dosing on RA
3mg/kg at 0, 2 and 6 weeks then 3mg/kg q 8 weeks
Anakinra (Kineret) indication and dose
RA - 100mg SC QD
Rilonacept (Arcalyst) indication and dose
CAPS and recurrent peri-carditis - 320mg SC followed by 160mg weekly beginning 1 week later (>12 yo)
Canakinumab (Ilaris) indication and dose
CAPS, FMF, HIDS, MKD, TRAPS - 150mg SC every 8 weeks;
Dupilumab (Dupixent) indication and dose
AD, Prurigo Nodularis: 600mg initially then 300mg every other week
EOE: 300mg once weekly
note PFS approved for >6 months; Pen for >2yo
Tocilizumab (Actemra) indication and dose
RA - SC - <100kg - 162mg every other week; >100kg - 162mg weekly; (IV 4-8mg/kg every 4 weeks)
GCA, ILD - 162mg SC weekly
Sarilumab (Kevzara) indication and dose
RA and Polymaylaiga Rheumatica - 200mg SC every 2 weeks
Tralokinumab (Adbry) indication and dose
AD - 600mg (4x150mg) initially then 300mg (2x150mg) every other week (<100kg pt - can consider 300mg every 4 weeks for clear skin after 16wks of tx)
Secukinumab (Cosentyx) indication and dose
PP - 300mg q wk for 5 weeks then 300mg every month
PsA/AS/nr-axSpA - 150mg q wk for 5 weeks then 150mg every month (LD is optional) - can increase to 300mg every 4 weeks
Ixekizumab (Taltz) indication and dose
AS/PsA - 160mg once then 80mg every 4 weeks
PP - 160mg once then 80mg week 2, 4, 6, 8, 10, 12 then 80mg every 8 weeks
nr-axSpA - 80mg every 4 weeks (no LD)
Brodalumab (Siliq) - indication and dose
PP - 210mg SC week 0, 1, 2 and then 210mg every 2 weeks
Ustekinumab (Stelara) - indication and dose
PP - <100kg - 45mg at week 0, 4, then every 12 weeks
>100kg - 90mg at week 0, 4, then every 12 weeks
PsA - 45mg at week 0, 4, then every 12 weeks
CD/UC - Induction IV then maintenance 90mg every 8 weeks begin 8 weeks after IV induction (single dose)
Tildrakizumab (Ilumya) - indication and dose
PP - 100mg week 0, 4, and q 12 weeks